Abstract
Children with detrusor overactivity, especially spina bifida and cerebral palsy kids, may also be good candidates for bladder botulinum toxin therapy. Effects on detrusor compliance, resolution of vesicoureteral reflux and/or hydronephrosis are some key questions raised when considering a child for bladder botulinum toxin injection (Schurch and Corcos 2005). This chapter focus on issues important for the use of botulinum toxin in pediatric population. We recommend the practitioner, especially those new to using botulinum toxin to read the (Chap. 3) neurogenic and (Chap. 4) idiopathic bladder chapters first. Consideration should be given to the appropriate dose of toxin in children, patient preparation and injection technique.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bauer SB, Hallett M, Khoshbin S et al (1984) Predictive value of urodynamic evaluation in newborns with myelodysplasia. JAMA 252:650–652
Chancellor MB (2010) Ten years single surgeon experience with botulinum toxin in the urinary tract; clinical observations and research discovery. Int Urol Nephrol 42:383–391
Corcos J, Al-Taweed W, Robichaud C (2004) Botulinum toxin as an alternative treatment to bladder augmentation in children with neurogenic bladder due to myelomeningocele [abstract]. J Urol 171:181
Edelstein RA, Bauer SB, Kelly MD et al (1995) The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 154:1500–1504
Hoebeke P, De Caestecker K, Vande Walle J, Dehoorne J, Raes A, Verleyen P, Van Laecke E (2006) The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. J Urol 176:328–330; discussion 330–331
Joseph DB, Bauer SB, Colodny AH et al (1989) Clean, intermittent catheterization of infants with neurogenic bladder. Pediatrics 84:78–82
Kuo HC (2007) Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity. J Urol 178:1359–1363
Mokhless I, Gaafar S, Fouda K, Shafik M, Assem A (2006) Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder. J Urol 176:1767–1770; discussion 1770
Neel KF, Soliman S, Salem M, Seida M, Al-Hazmi H, Khatab A (2007) Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder. J Urol 178:2593–2597; discussion 2597–2598
Radojicic ZI, Perovic SV, Milic NM (2006) Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin? J Urol 176:332–336; discussion 336
Riccabona M, Koen M, Schindler M et al (2004) Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171:845–848
Schulte-Baukloh H, Knispel HH, Michael T (2002a) Botulinum-A toxin in the treatment of neurogenic bladder in children. Pediatrics 110:420–421
Schulte-Baukloh H, Michael T et al (2002b) Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology 59:325–327; discussion 327–328
Schulte-Baukloh H, Michael T, Sturzebecher B, Knispel HH (2003) Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 44:139–143
Schulte-Baukloh H, Knispel HH, Stolze T, Weiss C, Michael T, Miller K (2005) Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity. Urology 66:865–870
Schurch B, Corcos J (2005) Botulinum toxin injections for paediatric incontinence. Curr Opin Urol 15:264–267
Smith CP, Chancellor MB (2004) Emerging role of botulinum toxin in the management of voiding dysfunction. J Urol 171:2128–2137
Smith CP, Chancellor MB (2005) Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection. J Endourol 19:880–882
Smith CP, Nishiguchi J et al (2005) Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65:37–41
Verleyen P, Hoebeke P, Raes P et al (2004) The use of botulinum toxin A in children with a non-neurogenic overactive bladder: a pilot study. BJU Int 93(suppl):69–72
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Chancellor, M.B., Smith, C.P. (2011). Pediatric Botulinum Toxin Applications. In: Botulinum Toxin in Urology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03580-7_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-03580-7_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03579-1
Online ISBN: 978-3-642-03580-7
eBook Packages: MedicineMedicine (R0)